Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Topiroxostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Topiroxostat, including repackagers and relabelers. The FDA regulates Topiroxostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Topiroxostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Topiroxostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Topiroxostat supplier is an individual or a company that provides Topiroxostat active pharmaceutical ingredient (API) or Topiroxostat finished formulations upon request. The Topiroxostat suppliers may include Topiroxostat API manufacturers, exporters, distributors and traders.
click here to find a list of Topiroxostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Topiroxostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Topiroxostat active pharmaceutical ingredient (API) in detail. Different forms of Topiroxostat DMFs exist exist since differing nations have different regulations, such as Topiroxostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Topiroxostat DMF submitted to regulatory agencies in the US is known as a USDMF. Topiroxostat USDMF includes data on Topiroxostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Topiroxostat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Topiroxostat suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Topiroxostat Drug Master File in Japan (Topiroxostat JDMF) empowers Topiroxostat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Topiroxostat JDMF during the approval evaluation for pharmaceutical products. At the time of Topiroxostat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Topiroxostat suppliers with JDMF on PharmaCompass.
Topiroxostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Topiroxostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Topiroxostat GMP manufacturer or Topiroxostat GMP API supplier for your needs.
A Topiroxostat CoA (Certificate of Analysis) is a formal document that attests to Topiroxostat's compliance with Topiroxostat specifications and serves as a tool for batch-level quality control.
Topiroxostat CoA mostly includes findings from lab analyses of a specific batch. For each Topiroxostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Topiroxostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Topiroxostat EP), Topiroxostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Topiroxostat USP).
LOOKING FOR A SUPPLIER?
